Acetabular reconstruction with human and bovine freeze-dried bone grafts and a reinforcement device.

Clinics
Ricardo RositoHumberto Moreira Palma

Abstract

This is a cohort trial (1997-2005) of 49 patients submitted to an acetabular component revision of a total hip arthroplasty, using impacted human and bovine freeze-dried cancellous bone grafts (H&FDBG) and a reinforcement device. To compare clinical/radiographic graft incorporation capability between cancellous bone grafts. There were two groups: I (n=26) receiving human grafts and II (n=25) receiving bovine grafts. The average follow-up times were 55 and 49 months, respectively. Clinical analysis was based on the Merle d'Aubigné and Postel score, and the radiographic analysis involved an established score based on Conn's et al. criteria for radiographic bone incorporation. No clinical/radiographic differences were found between the groups and both showed an overall rate of 88.5% and 76% of graft incorporation (p=0.424). The results presented here are comparable to those in the literature with the use of deep-FG. Therefore, cancellous bone grafts can be safely and adequately used in acetabular component revision in total hip arthroplasty.

Citations

Jul 29, 2020·Tissue Engineering. Part a·Sopita WonginKwanchanok Viravaidya-Pasuwat
Aug 30, 2014·Cell and Tissue Banking·Tiango Aguiar RibeiroCarlos Roberto Galia
May 4, 2010·BMC Musculoskeletal Disorders·Joscha BauerMarkus Dietmar Schofer
Jan 1, 2012·Revista Brasileira De Ortopedia·Carlos Roberto GaliaCarlos Alberto Souza Macedo
Dec 21, 2019·European Journal of Orthopaedic Surgery & Traumatology : Orthopédie Traumatologie·Nicola PiolantiMassimiliano Marcucci
Oct 3, 2017·Hip International : the Journal of Clinical and Experimental Research on Hip Pathology and Therapy·Elsa A SpaansStefan B T Bolder

❮ Previous
Next ❯

Methods Mentioned

BETA
total hip arthroplasty
xenografts
chips
heterograft
xenograft

Software Mentioned

SPSS

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

HSS Journal : the Musculoskeletal Journal of Hospital for Special Surgery
Kenny MaiClifford W Colwell
Scandinavian Journal of Work, Environment & Health
Jan H Pejtersen, Tage S Kristensen
Revista Panamericana De Salud Pública = Pan American Journal of Public Health
Abiodun Adewale AdesiyunAlva Stewart-Johnson
Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism
H F L GarretsenR J J M van den Eijnden
Arthritis Care & Research
Christopher J DyStephen Lyman
© 2022 Meta ULC. All rights reserved